Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $38.32 billion. The enterprise value is $38.28 billion.
| Market Cap | 38.32B |
| Enterprise Value | 38.28B |
Important Dates
The last earnings date was Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 133.51 million shares outstanding. The number of shares has increased by 6.45% in one year.
| Current Share Class | 133.51M |
| Shares Outstanding | 133.51M |
| Shares Change (YoY) | +6.45% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 0.37% |
| Owned by Institutions (%) | 99.22% |
| Float | 132.96M |
Valuation Ratios
The trailing PE ratio is 72.65 and the forward PE ratio is 34.90.
| PE Ratio | 72.65 |
| Forward PE | 34.90 |
| PS Ratio | 8.94 |
| Forward PS | 5.96 |
| PB Ratio | 35.61 |
| P/TBV Ratio | 35.63 |
| P/FCF Ratio | 59.56 |
| P/OCF Ratio | 53.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 47.43, with an EV/FCF ratio of 59.50.
| EV / Earnings | 71.15 |
| EV / Sales | 8.93 |
| EV / EBITDA | 47.43 |
| EV / EBIT | 50.89 |
| EV / FCF | 59.50 |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 2.76.
| Current Ratio | 3.13 |
| Quick Ratio | 2.88 |
| Debt / Equity | 2.76 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | 4.62 |
| Interest Coverage | 2.85 |
Financial Efficiency
Return on equity (ROE) is 90.36% and return on invested capital (ROIC) is 78.43%.
| Return on Equity (ROE) | 90.36% |
| Return on Assets (ROA) | 10.06% |
| Return on Invested Capital (ROIC) | 78.43% |
| Return on Capital Employed (ROCE) | 19.90% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | $1.71M |
| Profits Per Employee | $215,196 |
| Employee Count | 2,500 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 10.99 |
Taxes
In the past 12 months, ALNY has paid $9.18 million in taxes.
| Income Tax | 9.18M |
| Effective Tax Rate | 1.68% |
Stock Price Statistics
The stock price has increased by +7.26% in the last 52 weeks. The beta is 0.30, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +7.26% |
| 50-Day Moving Average | 312.86 |
| 200-Day Moving Average | 391.26 |
| Relative Strength Index (RSI) | 37.86 |
| Average Volume (20 Days) | 1,125,316 |
Short Selling Information
The latest short interest is 4.77 million, so 3.58% of the outstanding shares have been sold short.
| Short Interest | 4.77M |
| Short Previous Month | 5.03M |
| Short % of Shares Out | 3.58% |
| Short % of Float | 3.59% |
| Short Ratio (days to cover) | 4.25 |
Income Statement
In the last 12 months, ALNY had revenue of $4.29 billion and earned $537.99 million in profits. Earnings per share was $3.95.
| Revenue | 4.29B |
| Gross Profit | 3.46B |
| Operating Income | 752.14M |
| Pretax Income | 547.17M |
| Net Income | 537.99M |
| EBITDA | 806.94M |
| EBIT | 752.14M |
| Earnings Per Share (EPS) | $3.95 |
Balance Sheet
The company has $3.01 billion in cash and $2.97 billion in debt, with a net cash position of $38.99 million or $0.29 per share.
| Cash & Cash Equivalents | 3.01B |
| Total Debt | 2.97B |
| Net Cash | 38.99M |
| Net Cash Per Share | $0.29 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 8.06 |
| Working Capital | 2.87B |
Cash Flow
In the last 12 months, operating cash flow was $714.90 million and capital expenditures -$71.56 million, giving a free cash flow of $643.34 million.
| Operating Cash Flow | 714.90M |
| Capital Expenditures | -71.56M |
| Depreciation & Amortization | 54.81M |
| Net Borrowing | -546.95M |
| Free Cash Flow | 643.34M |
| FCF Per Share | $4.82 |
Margins
Gross margin is 80.83%, with operating and profit margins of 17.54% and 12.55%.
| Gross Margin | 80.83% |
| Operating Margin | 17.54% |
| Pretax Margin | 12.76% |
| Profit Margin | 12.55% |
| EBITDA Margin | 18.82% |
| EBIT Margin | 17.54% |
| FCF Margin | 15.01% |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.45% |
| Shareholder Yield | -6.45% |
| Earnings Yield | 1.40% |
| FCF Yield | 1.68% |
Analyst Forecast
The average price target for ALNY is $449.48, which is 63.88% higher than the current price. The consensus rating is "Buy".
| Price Target | $449.48 |
| Price Target Difference | 63.88% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (5Y) | 17.29% |
| EPS Growth Forecast (5Y) | 41.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 7.37 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.37 |
| Piotroski F-Score | 6 |